Retracted A. EFFICACY AND SAFETY OF ADALIMUMAB VERSUS INFLIXIMAB IN PATIENTS SUFFERED FROM MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS. Asian J Pharm Clin Res [Internet]. 2017 Mar. 1 [cited 2024 Nov. 4];10(3):300-7. Available from: https://journals.innovareacademics.in/index.php/ajpcr/article/view/16213